BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Acton Pharmaceuticals, Inc. 

225 Cedar Hill Street
Suite 337
Marlborough  Massachusetts  01752  U.S.A.
Phone: 508-624-8733 Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
MEDA: Acquisition of Acton Pharmaceuticals, Inc. Completed 10/21/2013 10:05:54 AM    More...
Meda AB (MEDA-A.ST) Snags U.S. Respiratory Company Acton Pharmaceuticals, Inc. for Up to $200 Million 8/30/2013 6:46:16 AM    More...
Acton Pharmaceuticals, Inc. Announces License Agreement with Sanofi U.S. for NASACORT HFA(TM) (triamcinolone acetonide) Nasal Aerosol 10/25/2011 6:57:41 AM    More...
Acton Pharmaceuticals, Inc. Announces Publication of AEROSPAN(R) (Flunisolide HFA) Pediatric Linear Growth Study in Annals of Allergy, Asthma & Immunology 10/11/2011 11:05:26 AM    More...
Acton Pharmaceuticals, Inc. Announces Additions to the Executive Management Team 5/5/2011 2:34:17 PM    More...
Acton Pharmaceuticals, Inc. Submits NDA Supplement to FDA for AEROSPAN(R) (flunisolide HFA, 80 mcg) Inhalation Aerosol 11/3/2010 10:16:12 AM    More...
Acton Pharmaceuticals, Inc. Forms Scientific Advisory Board 5/24/2010 9:58:55 AM    More...
Acton Pharmaceuticals, Inc. Announces Completion of $15 Million Series A Financing with Sequoia Capital 1/6/2010 7:09:22 AM    More...